China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Growth in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 63,600 shares, a growth of 142.7% from the March 31st total of 26,200 shares. Based on an average trading volume of 1,220,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 11.6% of the shares of the stock are sold short.

China SXT Pharmaceuticals Stock Up 1.9 %

NASDAQ:SXTC traded up $0.02 during mid-day trading on Friday, reaching $1.05. The stock had a trading volume of 203,439 shares, compared to its average volume of 2,344,629. The stock has a 50-day simple moving average of $1.68 and a two-hundred day simple moving average of $2.01. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.41 and a current ratio of 1.47. China SXT Pharmaceuticals has a 12 month low of $0.94 and a 12 month high of $9.38.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.